NCT03177863View on ClinicalTrials.gov

Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age

NACompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

June 12, 2017

Primary Completion Date

June 24, 2021

Study Completion Date

June 24, 2021

Conditions

CIN2Therapy

Interventions

PROCEDURE

Expectancy

Clinical monitoring. See arm description

Trial Locations (5)

43350

Kungshöjds gynekologmottagning, Gothenburg

Unknown

Södra Älvsborgs Sjukhus, Borås

Frölunda specialistsjukhus, Gothenburg

Skaraborgs sjukhus, kvinnokliniken, Skövde

Norra Älvsborgs sjukhus, kvinnokliniken, Trollhättan

All Listed Sponsors

lead

Sahlgrenska University Hospital

OTHER

NCT03177863 - Expectancy as Alternative to Treatment for Cervical Intraepithelial Neoplasia Grade 2 Among Women 25 - 30 Years of Age | Biotech Hunter | Biotech Hunter